{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:38:10Z","timestamp":1770813490445,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.drugalcdep.2017.10.035","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T18:41:36Z","timestamp":1513017696000},"page":"127-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine\/naloxone maintenance treatment"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1545-4457","authenticated-orcid":false,"given":"Francisco","family":"Gonz\u00e1lez-Saiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-6563","authenticated-orcid":false,"given":"Oscar","family":"Lozano Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Trujols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5720-8801","authenticated-orcid":false,"given":"Saul","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Si\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"P\u00e9rez de los Cobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1300\/J069v13n03_04","article-title":"A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification","volume":"13","author":"Amass","year":"1994","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0015","series-title":"The Effectiveness of Methadone Maintenance Treatment","author":"Ball","year":"1991"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)20047-7","article-title":"Buprenorphine: dose related blockade of opioid challenge effects in opioid dependent humans","volume":"247","author":"Bickel","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","article-title":"Quality of life as an outcome of opioid use disorder treatment: a systematic review","volume":"76","author":"Bray","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of test","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0040","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3109\/10826084.2013.800886","article-title":"METODO Study Team,. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addictied patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation","volume":"48","author":"D\u2019Egidio","year":"2013","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000259165","article-title":"Opiate craving and the presence of psychopathology","volume":"3","author":"De Vos","year":"1997","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0050","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/dar.12205","article-title":"Excess mortality among opioid-using patients treated with oral naltrexone in Australia","volume":"34","author":"Degenhardt","year":"2015","journal-title":"Drug Alcohol Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2017.10.035_bib0060","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1046\/j.1360-0443.95.11s3.5.x","article-title":"Truth or consequences: the validity of self-report data in health services research on addictions","volume":"95","author":"Del Boca","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-3-105","article-title":"The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol","volume":"3","author":"Dennis","year":"2014","journal-title":"Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0070","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1001\/jama.1988.03410200081030","article-title":"Implications of methadone maintenance for theories of narcotic addiction","volume":"260","author":"Dole","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0075","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptom complaints in methadone maintenance patients","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10550887.2011.642758","article-title":"Effect of buprenorphine dose on treatment outcome","volume":"31","author":"Fareed","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2013.10.011","article-title":"Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review","volume":"134","author":"Feelemyer","year":"2014","journal-title":"Drug Alcohol Dep."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/clpt.1990.67","article-title":"Use of buprenorphine in the treatment of opioid addiction: II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","volume":"47","author":"Fudala","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"A scaled version of the general health questionnaire","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0115","first-page":"223","article-title":"Estudio de fiabilidad y validez de la versi\u00f3n espa\u00f1ola de la escala Severity of Dependence Scale (SDS)","volume":"10","author":"Gonz\u00e1lez-Saiz","year":"1998","journal-title":"Adicciones"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0120","first-page":"25","article-title":"Evidence of reliability and validity of the Opiate Dosage Adequacy Scale (ODAS) in a sample of methadone maintenance patients","volume":"10","author":"Gonz\u00e1lez-Saiz","year":"2008","journal-title":"Heroin Addict. Rel. Clin. Probl."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0125","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/10826080701801543","article-title":"Validity of the Severity of Dependence Scale (SDS) construct applying the item response theory to a non-clinical simple of heroin users","volume":"43","author":"Gonz\u00e1lez-Saiz","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000189787","article-title":"Severity of Dependence Scale as a diagnostic tool for heroin and cocaine dependence","volume":"15","author":"Gonz\u00e1lez-Saiz","year":"2009","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0135","first-page":"41","article-title":"Opiate Dosage Adequacy Scale (O.D.A.S.): A clinical diagnostic tool as a guide to dosing decisions","volume":"6","author":"Gonz\u00e1lez-Saiz","year":"2004","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0140","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS): Psychometric propierties of the SDS in English and Australian samples of heroin, cocaine and amphetamines users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-017-1415-y","article-title":"Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine","volume":"17","author":"Heikman","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/00952990.2011.596974","article-title":"Participant characteristics and buprenorphine dose","volume":"37","author":"Hillhouse","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02245829","article-title":"Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients","volume":"118","author":"Hiltunen","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0170","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: how to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02289743","article-title":"Alpha factor analysis","volume":"30","author":"Kaiser","year":"1965","journal-title":"Psychometrika"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02291817","article-title":"A second generation little jiffy","volume":"35","author":"Kaiser","year":"1970","journal-title":"Psychometrika"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pec.2014.06.014","article-title":"Twelve myths about shared decision making","volume":"96","author":"L\u00e9gar\u00e9","year":"2014","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0376-8716(90)90078-S","article-title":"Safety and side-effects of buprenorphine in the clinical management of heroin addiction","volume":"26","author":"Lange","year":"1990","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0195","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0200","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S0033291700002579","article-title":"Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population","volume":"16","author":"Lobo","year":"1986","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005053-198507000-00005","article-title":"New data from the Addiction Severity Index: reliability and vaidity in three centers","volume":"173","author":"McLellan","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0215","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.addbeh.2014.09.021","article-title":"Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model","volume":"41","author":"Northrup","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0220","series-title":"Psychometric Theory","author":"Nunnally","year":"1994"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.drugalcdep.2005.03.021","article-title":"Patient perspectives on methadone maintenance treatment in the Valencia Region Dose adjustment, participation in dosage regulation, and satisfaction with treatment","volume":"79","author":"P\u00e9rez de los Cobos","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-9-13","article-title":"When higher doses in opioid replacement treatment are still inadequate \u2212association to multidimensional illness severity: a cohort study","volume":"9","author":"Reimer","year":"2014","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/ADM.0b013e318297021e","article-title":"Meaning and methadone: patient perceptions of methadone dose and a model to promote adherence to maintenance treatment","volume":"7","author":"Sanders","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0245","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0033-1355363","article-title":"Die Opiate Dosage Adequacy Scale (ODAS) f\u00fcr die beurteilung der angemessenheith der buprenorphindosierung w\u00e4hrend der opiatsubstitution","volume":"14","author":"Schulte","year":"2013","journal-title":"Suchttherapie"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsat.2004.06.001","article-title":"A conceptual framework for drug treatment process and outcomes","volume":"27","author":"Simpsom","year":"2004","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0255","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1360-0443.1992.tb01956.x","article-title":"The validity of self-reported drug use","volume":"87","author":"Skog","year":"1992","journal-title":"Br. J. Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0260","series-title":"Applied Multivariate Statistics for the Social Sciences","author":"Stevens","year":"1992"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0265","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12860","article-title":"Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study","volume":"110","author":"Teesson","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0270","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1176\/appi.ps.201300256","article-title":"Medication-assisted treatment with buprenorphine: assessing the evidence","volume":"65","author":"Thomas","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0275","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.pmed.0030080","article-title":"Determining effective methadone doses for individual opioid-dependent patients","volume":"3","author":"Trafton","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JCP.0b013e3181c8b439","article-title":"Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment","volume":"30","author":"Trujols","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0285","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.pec.2016.12.001","article-title":"Patient perception of methadone dose adequacy in methadone maintenance treatment: the role of perceived participations in dosage decisions","volume":"100","author":"Trujols","year":"2017","journal-title":"Patient Educ. Couns."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0290","article-title":"World drug report 2016","author":"United Nations Office on Drugs and Crime","year":"2016","journal-title":"United Nations Office on Drugs and Crime, Wien"},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4321\/S0211-57352015000300002","article-title":"Aspectos conceptuales sobre el proceso de decisi\u00f3n compartida en salud mental [Conceptual analysis of shared decision-making process in mental health]","volume":"35","author":"Villagr\u00e1n","year":"2015","journal-title":"Rev. Asoc. Esp. Neuropsiq."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0300","first-page":"1","article-title":"The opiate dosage adequacy scale for identification of the right methadone dose \u2013 a prospective cohort study","volume":"17","author":"Walcher","year":"2016","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0305","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0310","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans: partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2017.10.035_bib0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2004.01.009","article-title":"Variations in evidence-based clinical practices in nine United States Veterans Administration opioid agonist therapy clinics","volume":"75","author":"Willenbring","year":"2004","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617305914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T13:52:23Z","timestamp":1751118743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617305914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":63,"alternative-id":["S0376871617305914"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine\/naloxone maintenance treatment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}